ZA89523B - Use of a benzamide - Google Patents
Use of a benzamideInfo
- Publication number
- ZA89523B ZA89523B ZA89523A ZA89523A ZA89523B ZA 89523 B ZA89523 B ZA 89523B ZA 89523 A ZA89523 A ZA 89523A ZA 89523 A ZA89523 A ZA 89523A ZA 89523 B ZA89523 B ZA 89523B
- Authority
- ZA
- South Africa
- Prior art keywords
- benzamide
- morpholinoethyl
- chloro
- treating
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH29888 | 1988-01-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA89523B true ZA89523B (en) | 1989-09-27 |
Family
ID=4183804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA89523A ZA89523B (en) | 1988-01-28 | 1989-01-23 | Use of a benzamide |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4906626A (xx) |
| EP (1) | EP0326023B1 (xx) |
| JP (1) | JPH07116043B2 (xx) |
| KR (1) | KR960016203B1 (xx) |
| AT (1) | ATE113207T1 (xx) |
| AU (1) | AU620584B2 (xx) |
| CA (1) | CA1332151C (xx) |
| DE (1) | DE58908544D1 (xx) |
| DK (1) | DK171094B1 (xx) |
| ES (1) | ES2063060T3 (xx) |
| HU (1) | HU203042B (xx) |
| IE (1) | IE65409B1 (xx) |
| IL (1) | IL89031A (xx) |
| PH (1) | PH26030A (xx) |
| ZA (1) | ZA89523B (xx) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0559297B1 (en) * | 1986-12-17 | 1997-05-07 | Glaxo Group Limited | Use of heterocyclic derivatives for the manufacture of medicaments |
| FR2645742A1 (fr) * | 1989-04-12 | 1990-10-19 | Delagrange Laboratoires | Application de derives de 2-methoxy 4-(4,5-dihydro 2-imidazolyl (ou 2-oxazolyl) amino) 5-chloro benzamide dans le traitement des troubles de la fonction cognitive |
| JP3172202B2 (ja) * | 1990-11-29 | 2001-06-04 | エフ．ホフマン−ラ ロシュ アーゲー | 不安の障害の処置剤 |
| US6951884B2 (en) * | 2002-06-12 | 2005-10-04 | Hoffmann-La Roche Inc. | Fluorobenzamides and uses thereof |
| AU2004283452A1 (en) * | 2003-10-23 | 2005-05-06 | F. Hoffmann-La Roche Ag | Benzazepine derivatives as MAO-B inhibitors |
| WO2005053703A1 (en) * | 2003-12-02 | 2005-06-16 | Leslie James Sheldon | Combination therapy for dementia, depression and apathy |
| CA2628074C (en) | 2005-10-25 | 2014-01-14 | Shionogi & Co., Ltd. | Aminodihydrothiazine derivative |
| WO2008133273A1 (ja) * | 2007-04-24 | 2008-11-06 | Shionogi & Co., Ltd. | アルツハイマー症治療用医薬組成物 |
| KR20100017255A (ko) * | 2007-04-24 | 2010-02-16 | 시오노기 앤드 컴파니, 리미티드 | 환식기로 치환된 아미노다이하이드로싸이아진 유도체 |
| US8637504B2 (en) | 2008-06-13 | 2014-01-28 | Shionogi & Co., Ltd. | Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity |
| US8703785B2 (en) * | 2008-10-22 | 2014-04-22 | Shionogi & Co., Ltd. | 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having BACE1-inhibiting activity |
| US8999980B2 (en) | 2009-12-11 | 2015-04-07 | Shionogi & Co., Ltd. | Oxazine derivatives |
| JP5766198B2 (ja) | 2010-10-29 | 2015-08-19 | 塩野義製薬株式会社 | 縮合アミノジヒドロピリミジン誘導体 |
| EP2634186A4 (en) | 2010-10-29 | 2014-03-26 | Shionogi & Co | naphthyridine |
| EP2703399A4 (en) | 2011-04-26 | 2014-10-15 | Shionogi & Co | OXAZINE DERIVATIVE AND BACE-1 HEMMER THEREOF |
| WO2014065434A1 (en) | 2012-10-24 | 2014-05-01 | Shionogi & Co., Ltd. | Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity |
| US10599006B2 (en) | 2016-04-12 | 2020-03-24 | E-Vision Smart Optics, Inc. | Electro-active lenses with raised resistive bridges |
| ES2973138T3 (es) | 2016-04-12 | 2024-06-18 | E Vision Smart Optics Inc | Lentes electroactivas con puentes resistivos elevados |
-
1989
- 1989-01-11 CA CA000587927A patent/CA1332151C/en not_active Expired - Lifetime
- 1989-01-13 US US07/297,168 patent/US4906626A/en not_active Expired - Lifetime
- 1989-01-19 EP EP89100901A patent/EP0326023B1/de not_active Expired - Lifetime
- 1989-01-19 AT AT89100901T patent/ATE113207T1/de not_active IP Right Cessation
- 1989-01-19 DE DE58908544T patent/DE58908544D1/de not_active Expired - Lifetime
- 1989-01-19 ES ES89100901T patent/ES2063060T3/es not_active Expired - Lifetime
- 1989-01-23 ZA ZA89523A patent/ZA89523B/xx unknown
- 1989-01-23 IL IL8903189A patent/IL89031A/en unknown
- 1989-01-25 HU HU89303A patent/HU203042B/hu unknown
- 1989-01-25 JP JP1014249A patent/JPH07116043B2/ja not_active Expired - Lifetime
- 1989-01-27 KR KR1019890000867A patent/KR960016203B1/ko not_active IP Right Cessation
- 1989-01-27 IE IE27389A patent/IE65409B1/en not_active IP Right Cessation
- 1989-01-27 PH PH38119A patent/PH26030A/en unknown
- 1989-01-27 AU AU28836/89A patent/AU620584B2/en not_active Expired
- 1989-01-27 DK DK036889A patent/DK171094B1/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK36889D0 (da) | 1989-01-27 |
| DK171094B1 (da) | 1996-06-03 |
| JPH01224318A (ja) | 1989-09-07 |
| DE58908544D1 (de) | 1994-12-01 |
| HUT50042A (en) | 1989-12-28 |
| CA1332151C (en) | 1994-09-27 |
| JPH07116043B2 (ja) | 1995-12-13 |
| KR960016203B1 (ko) | 1996-12-06 |
| PH26030A (en) | 1992-01-29 |
| AU620584B2 (en) | 1992-02-20 |
| US4906626A (en) | 1990-03-06 |
| DK36889A (da) | 1989-07-29 |
| AU2883689A (en) | 1989-08-03 |
| EP0326023A2 (de) | 1989-08-02 |
| EP0326023A3 (en) | 1990-09-05 |
| HU203042B (en) | 1991-05-28 |
| IE890273L (en) | 1989-07-28 |
| ES2063060T3 (es) | 1995-01-01 |
| IL89031A (en) | 1995-07-31 |
| IL89031A0 (en) | 1989-08-15 |
| EP0326023B1 (de) | 1994-10-26 |
| IE65409B1 (en) | 1995-10-18 |
| ATE113207T1 (de) | 1994-11-15 |
| KR890011589A (ko) | 1989-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA89523B (en) | Use of a benzamide | |
| EP0326034A3 (en) | Combination for the treatment of nervous cells and fibers illnesses and disorders | |
| GR3006001T3 (xx) | ||
| EP0332356A3 (en) | Supply of carbon dioxide | |
| OA09362A (en) | "Production and use of porphyrins". | |
| NO172627C (no) | Fremgangsmaate for fjernelse av hydrogensulfid med spesielle jernoksyder | |
| EP0305890A3 (en) | Use of bezafibrate for the treatment of diabetes | |
| ZA878055B (en) | A therapeutically useful compound | |
| ZA871062B (en) | Use of aromatic diamines for the treatment of angina and diamines therefor | |
| EP0243645A3 (en) | Compounds having a nootropic activity, agents containing them and their use in the treatment and prophylaxis of cognitive malfunctions | |
| EP0406211A3 (en) | Fucosidase inhibitors | |
| DE3879535D1 (xx) | ||
| ZA886249B (en) | Use of a compound for the treatment of sleep disorders and depression | |
| IL89082A0 (en) | Compounds with a psychotropic action,agents containing them,and the use thereof for the treatment and prophylaxis of disorders of the central nervous system | |
| EP0532629A4 (xx) | ||
| EP0177965A3 (en) | Novel oxa- and thiadiazolyl derivatives and their use | |
| EP0270782A3 (en) | Therapeutic agents for the prophylaxis of tumour metastasis | |
| DE3667109D1 (en) | Liquid for the treatment of a photoresist composition, and process therefor | |
| EP0405376A3 (en) | Characterization of viruses | |
| IE892586L (en) | Use of zofenopril for the treatment of rheumatoid arthritis | |
| DE3273177D1 (en) | Trans-dihyldrolisuride antipsychotic | |
| GR3004866T3 (xx) | ||
| AU8981891A (en) | Use of certain esters of hexahydro-8-hydroxy-2,6-methano- 2h-quinolizin-3(4h)-one and related compounds for treating cognitive disorders | |
| IT1231433B (it) | Procedimento per produrre pezzi stampati e dispositivo per l'esecuzione del procedimento. | |
| ZA893606B (en) | Use of diazepinones for treating disorders of the microcirculation |